Windtree Therapeutics - שולי רווח נקי ממכירות WINT

סמל מסחרי של Windtree (WINT)

Windtree Therapeutics (WINT) does not pay dividends, focusing instead on saving lives in intensive care. Net income per unit of sales serves as a confidence indicator, where the value of 0.00 characterizes this level. Windtree Therapeutics (WINT) is creating the unique Istaroxime to combat heart failure. Meanwhile, strict capital austerity necessitates maintaining a minimal staff of specialists motivated solely by future stock options.

Windtree Therapeutics, Inc. (WINT) - שולי רווח נקי מ-04.07.2022 עד 06.09.2025

WINT (Windtree Therapeutics, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- מחיר מניה וקונצנזוס הערכת שווי:
ניתוח כללי של החברה:Windtree Therapeutics Inc. - WINT
סחורת הדגל של windtreetx.com

Sales margins determine the share of net profit in every dollar of revenue, reflecting the overall efficiency of the business. An analysis of the net margin from core operations allows for an assessment of the company's ability to convert revenue into real capital. This metric is calculated as the ratio of net profit to total sales volume. The trend of this indicator is critical for Windtree Therapeutics (WINT), as it demonstrates the financial return from the development of cardiology drugs within strategic alliances with clinics.